This inventor holds 1 USPTO granted patent. Top assignee: Medigen Biotechnology Corporation. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Young-Sun Lin: Innovator in H1N1 Antibody Development
Introduction
Young-Sun Lin is a prominent inventor based in Taipei, Taiwan. He is known for his significant contributions to biotechnology, particularly in the development of antibodies against the H1N1 flu virus. His innovative work has the potential to impact public health positively.
Latest Patents
Young-Sun Lin holds a patent for H1N1 flu virus neutralizing antibodies. This patent describes an antibody, or a binding fragment of the antibody, that targets the H1N1 virus. The antibody includes a heavy chain variable region and a light chain variable region, with specific amino acid sequences that enhance its effectiveness. The patent outlines a method for treating or preventing H1N1 infection in a subject by administering the antibody or its binding fragment.
Career Highlights
Young-Sun Lin is affiliated with Medigen Biotechnology Corporation, where he applies his expertise in antibody development. His work at the company has positioned him as a key player in the field of biotechnology, particularly in the fight against viral infections.
Collaborations
Young-Sun Lin collaborates with notable colleagues, including Kuei-Tai Lai and Huei-Luen Huang. Their combined efforts contribute to advancements in biotechnology and the development of effective treatments for viral infections.
Conclusion
Young-Sun Lin's innovative work in developing antibodies against the H1N1 virus showcases his commitment to improving public health through biotechnology. His contributions are vital in the ongoing battle against infectious diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile